AI Decision Support for Breast Ultrasound May Reduce Benign Biopsies
A retrospective two-center study found an FDA-cleared AI tool classified 60.6 percent of benign BI-RADS 4 breast lesions as probably ...
A retrospective two-center study found an FDA-cleared AI tool classified 60.6 percent of benign BI-RADS 4 breast lesions as probably ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.